<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">asurgery</journal-id><journal-title-group><journal-title xml:lang="ru">Амбулаторная хирургия</journal-title><trans-title-group xml:lang="en"><trans-title>Ambulatornaya khirurgiya = Ambulatory Surgery (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2712-8741</issn><issn pub-type="epub">2782-2591</issn><publisher><publisher-name>ООО «ГРУППА РЕМЕДИУМ»</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">asurgery-6</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ФЛЕБОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PHLEBOLOGY</subject></subj-group></article-categories><title-group><article-title>Фармакотерапия хронических заболеваний вен: возможности сулодексида</article-title><trans-title-group xml:lang="en"><trans-title></trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ширинбек</surname><given-names>О. .</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Многопрофильный медицинский холдинг «СМ-Клиника»</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="epub"><day>20</day><month>06</month><year>2015</year></pub-date><volume>0</volume><issue>1-2</issue><fpage>26</fpage><lpage>30</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ширинбек О..., 2015</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="ru">Ширинбек О...</copyright-holder><copyright-holder xml:lang="en">Ширинбек О...</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.a-surgeon.ru/jour/article/view/6">https://www.a-surgeon.ru/jour/article/view/6</self-uri><abstract><p>Хронические заболевания вен (ХЗВ) относятся к наиболее распространенным патологиям периферических сосудов. Этими заболеваниями страдают более половины населения мира. ХЗВ имеют не только большое медицинское значение, но также оказывают значительный социально-экономический эффект, который только усиливается омоложением этого заболевания в последние годы. Одним из компонентов комплексной терапии ХЗВ являются антикоагулянты прямого действия, в частности сулодексид (Вессел Дуэ Ф, «Альфа Вассерманн»). При лечении ХЗВ, сопровождающихся отеками и трофическими нарушениями, сулодексид может способствовать замедлению прогрессирования признаков и симптомов заболевания у пациентов со всеми клиническими классами тяжести ХЗВ (от С1 до С6).</p></abstract><kwd-group xml:lang="ru"><kwd>хронические заболевания вен</kwd><kwd>патофизиология</kwd><kwd>гемодинамика</kwd><kwd>антикоагулянт прямого действия</kwd><kwd>сулодексид</kwd><kwd>Вессел Дуэ Ф</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Коваленко В., Калитко И., Темрезов М., Чемурзиев Р., Петров А. Возможности лечения больных с атеротромботичес-ким поражением артерий нижних конечностей. Врач, 2010, 3: 1-3.</mixed-citation><mixed-citation xml:lang="en">Коваленко В., Калитко И., Темрезов М., Чемурзиев Р., Петров А. Возможности лечения больных с атеротромботичес-ким поражением артерий нижних конечностей. Врач, 2010, 3: 1-3.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Российские клинические рекомендации по диагностике и лечению хронических заболеваний вен. Флебология, 2013, 2: 47.</mixed-citation><mixed-citation xml:lang="en">Российские клинические рекомендации по диагностике и лечению хронических заболеваний вен. Флебология, 2013, 2: 47.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Токмакова А.Ю., Анциферов М.Б., Дедов И.И. Медикаментозная терапия ишемии нижних конечностей у больных сахарным диабетом 2-го типа. Сахарный диабет, 1999, 16: 39-42.</mixed-citation><mixed-citation xml:lang="en">Токмакова А.Ю., Анциферов М.Б., Дедов И.И. Медикаментозная терапия ишемии нижних конечностей у больных сахарным диабетом 2-го типа. Сахарный диабет, 1999, 16: 39-42.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Аndreozzi GM, Cordova RM, Scomparin A et ai. Quality of life in chronic venous insufficiency. An Italian pilot study of the Triveneto Region. Int Angiol., 2005, 24(3): 272-7.</mixed-citation><mixed-citation xml:lang="en">Аndreozzi GM, Cordova RM, Scomparin A et ai. Quality of life in chronic venous insufficiency. An Italian pilot study of the Triveneto Region. Int Angiol., 2005, 24(3): 272-7.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Andreozzi G.M., Paiareti G. Rationale and study design of the SURVET trial (Suiodexide in Secondary Prevention of Recurrent Deep Vein Thrombosis).Pathophysioiogy of hemostasis and thrombosis. Proceedings for the 21st International Congress on Thrombosis, Milan, July 5-9, 2010; 37:9-10, p.302.</mixed-citation><mixed-citation xml:lang="en">Andreozzi G.M., Paiareti G. Rationale and study design of the SURVET trial (Suiodexide in Secondary Prevention of Recurrent Deep Vein Thrombosis).Pathophysioiogy of hemostasis and thrombosis. Proceedings for the 21st International Congress on Thrombosis, Milan, July 5-9, 2010; 37:9-10, p.302.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Andreozzi GM. Suiodexide in the treatment of chronic venous disease. Am J Cardiovasc Drugs, 2012; doi 10.2165.</mixed-citation><mixed-citation xml:lang="en">Andreozzi GM. Suiodexide in the treatment of chronic venous disease. Am J Cardiovasc Drugs, 2012; doi 10.2165.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Bergan JJ, Schmid-Schonbein GW, Smith PD, et ai. Chronic venous disease. N Engl J Med, 2006, 3; 355(5):488-98.</mixed-citation><mixed-citation xml:lang="en">Bergan JJ, Schmid-Schonbein GW, Smith PD, et ai. Chronic venous disease. N Engl J Med, 2006, 3; 355(5):488-98.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Capone-Braga M, Teiiini L, Boncompagni L, et ai. Suiodexide treatment approach in patients with atheroscierotic vascuiar disease with various iocaiizations. Clin Ter, 1987, 15; 120 (1):25-31.</mixed-citation><mixed-citation xml:lang="en">Capone-Braga M, Teiiini L, Boncompagni L, et ai. Suiodexide treatment approach in patients with atheroscierotic vascuiar disease with various iocaiizations. Clin Ter, 1987, 15; 120 (1):25-31.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Carpentier PH, Maricq HR, Biro C, et ai. Prevaience, risk factors and ciinicai patterns of chronic venous disorders of iower iimbs. A popuiation-based study in France. J VascSurg, 2004, 40: 650-659.</mixed-citation><mixed-citation xml:lang="en">Carpentier PH, Maricq HR, Biro C, et ai. Prevaience, risk factors and ciinicai patterns of chronic venous disorders of iower iimbs. A popuiation-based study in France. J VascSurg, 2004, 40: 650-659.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Cirujeda LJ, Granado CP. A study on the safety, efficacy, and efficiency of suiodexide compared with acenocumaroi in secondary prophyiaxis in patients with deep venous thrombosis. Angiology, 2-6, 57(1): 53-64.</mixed-citation><mixed-citation xml:lang="en">Cirujeda LJ, Granado CP. A study on the safety, efficacy, and efficiency of suiodexide compared with acenocumaroi in secondary prophyiaxis in patients with deep venous thrombosis. Angiology, 2-6, 57(1): 53-64.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Ciszewicz M, Poiubinska A, Antoniewicz AA et ai. Suiodexide suppresses infiammation in human endotheiiai ceiis and prevents giucose cytotoxicity. Transl Res, 2009, 153(3): 118-23.</mixed-citation><mixed-citation xml:lang="en">Ciszewicz M, Poiubinska A, Antoniewicz AA et ai. Suiodexide suppresses infiammation in human endotheiiai ceiis and prevents giucose cytotoxicity. Transl Res, 2009, 153(3): 118-23.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Coccheri S, Scondotto G, Agneiii G, Aioisi D et ai. Randomised, doubie-biind, muiticentre, piacebo controiied study of suiodexide in the treatment of venous ieg uicers. Thromb Haemost, 2002, 87:947-52.</mixed-citation><mixed-citation xml:lang="en">Coccheri S, Scondotto G, Agneiii G, Aioisi D et ai. Randomised, doubie-biind, muiticentre, piacebo controiied study of suiodexide in the treatment of venous ieg uicers. Thromb Haemost, 2002, 87:947-52.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Coccheri S, Scondotto G, Agneiii G, Paiazzini E et ai. Suiodexide in the treatment of intermittent ciaudication. Resuits of a randomised, doubie-biind, muiticentre, piacebo-controiied study. European Heart Journal, 2002, 23:1057-1065.</mixed-citation><mixed-citation xml:lang="en">Coccheri S, Scondotto G, Agneiii G, Paiazzini E et ai. Suiodexide in the treatment of intermittent ciaudication. Resuits of a randomised, doubie-biind, muiticentre, piacebo-controiied study. European Heart Journal, 2002, 23:1057-1065.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Cosmi B, Cini M, Legnani C, et ai. Additive thrombin inhibition by fast moving heparin and dermatan suifate expiains the anti-coaguiant effect of suiodexide? A naturai mixture of giy-cosaminogiicans. Thromb Res, 2003, 15, 109 (5-6):333-9.</mixed-citation><mixed-citation xml:lang="en">Cosmi B, Cini M, Legnani C, et ai. Additive thrombin inhibition by fast moving heparin and dermatan suifate expiains the anti-coaguiant effect of suiodexide? A naturai mixture of giy-cosaminogiicans. Thromb Res, 2003, 15, 109 (5-6):333-9.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Cospite M, Ferrara F, Cospite V, Paiazzini E. Suiodexide and the microcircuiatory component in microphiebopathies. Current Medical Research and Opinion, 1992, 13(1): 56-60.</mixed-citation><mixed-citation xml:lang="en">Cospite M, Ferrara F, Cospite V, Paiazzini E. Suiodexide and the microcircuiatory component in microphiebopathies. Current Medical Research and Opinion, 1992, 13(1): 56-60.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Current aspects in chronic venous disease: focus on suiodex-ide. International Angiology, 2014, 33(3): 209-274.</mixed-citation><mixed-citation xml:lang="en">Current aspects in chronic venous disease: focus on suiodex-ide. International Angiology, 2014, 33(3): 209-274.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Errichi BM, Cesarone MR, Beicaro G, Marinucci R et ai. Prevention of recurrent deep venous thrombosis with suiodexide: The SanVai Registry. Angiology, 2004, 55(3): 243-249.</mixed-citation><mixed-citation xml:lang="en">Errichi BM, Cesarone MR, Beicaro G, Marinucci R et ai. Prevention of recurrent deep venous thrombosis with suiodexide: The SanVai Registry. Angiology, 2004, 55(3): 243-249.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Gaddi A, Gaietti C, Iiiuminati B, Nascetti S. Meta-anaiysis of some resuits of ciinicai triais on suiodexide therapy in periph-erai occiusive arteriai disease. The Journal of International Medical Research, 1996, 24: 389-406.</mixed-citation><mixed-citation xml:lang="en">Gaddi A, Gaietti C, Iiiuminati B, Nascetti S. Meta-anaiysis of some resuits of ciinicai triais on suiodexide therapy in periph-erai occiusive arteriai disease. The Journal of International Medical Research, 1996, 24: 389-406.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Gioviczki P, Comerota AJ, Daising MC et ai. The care of patients with varicose veins and associated chronic venous diseases: ciinicai practice guideiines of the Society for Vascuiar Surgery and the American Venous Forum. J Vasc Surg, 2011, 53(5): 2S-48S.</mixed-citation><mixed-citation xml:lang="en">Gioviczki P, Comerota AJ, Daising MC et ai. The care of patients with varicose veins and associated chronic venous diseases: ciinicai practice guideiines of the Society for Vascuiar Surgery and the American Venous Forum. J Vasc Surg, 2011, 53(5): 2S-48S.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Guideiines Itaiian Coiiege of Phieboiogy Revision 2013. International Angiology, 2013, 32, Suppi.1 to issue No 4, 140p.</mixed-citation><mixed-citation xml:lang="en">Guideiines Itaiian Coiiege of Phieboiogy Revision 2013. International Angiology, 2013, 32, Suppi.1 to issue No 4, 140p.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Jawien A, Grzeia T, Ochwat A. Prevaience of chronic venous insufficiency in men and women in Poiand: muiticenter cross-sectionai study in 40 095 patients. Phlebology, 2003, 18: 110-121.</mixed-citation><mixed-citation xml:lang="en">Jawien A, Grzeia T, Ochwat A. Prevaience of chronic venous insufficiency in men and women in Poiand: muiticenter cross-sectionai study in 40 095 patients. Phlebology, 2003, 18: 110-121.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Kearon C, Kahn SR, Agneiii G, et ai. Antothrombotic therapy for venous thromboemboiic disease: American Coiiege of Chest Physicians evidence-based ciinicai practice guideiines (8th ed.). Chest, 2008, 133(6): 454S-545S.</mixed-citation><mixed-citation xml:lang="en">Kearon C, Kahn SR, Agneiii G, et ai. Antothrombotic therapy for venous thromboemboiic disease: American Coiiege of Chest Physicians evidence-based ciinicai practice guideiines (8th ed.). Chest, 2008, 133(6): 454S-545S.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Kistner RL, Ekiof B, Masuda EM. Diagnosis of chronic venous disease of the iower extremities: the «CEAP» ciassification. Mayo Ciin Proc, 1996; 71: 338-345.</mixed-citation><mixed-citation xml:lang="en">Kistner RL, Ekiof B, Masuda EM. Diagnosis of chronic venous disease of the iower extremities: the «CEAP» ciassification. Mayo Ciin Proc, 1996; 71: 338-345.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Kucharzewski M, Franek A, Kozioiek H. Treatment of venous ieg uicers with suiodexide. Phlebologie, 2003, 32: 115-20.</mixed-citation><mixed-citation xml:lang="en">Kucharzewski M, Franek A, Kozioiek H. Treatment of venous ieg uicers with suiodexide. Phlebologie, 2003, 32: 115-20.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Lauver DA, Booth EA, White AJ et ai. Suiodexide attenuates myocardiai ischemia/reperfusion injury and the deposition of C-reactive protein in areas of infarction without affecting hemostasis. J Pharmacol Exp Ther, 2005, 312(2): 794-800.</mixed-citation><mixed-citation xml:lang="en">Lauver DA, Booth EA, White AJ et ai. Suiodexide attenuates myocardiai ischemia/reperfusion injury and the deposition of C-reactive protein in areas of infarction without affecting hemostasis. J Pharmacol Exp Ther, 2005, 312(2): 794-800.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Maneiio F, Raffetto JD. Matrix metaiioproteinase activity and giycosaminogiycans in chronic venous disease: the iinkage among ceii bioiogy, pathoiogy and transiationai research. Am J Transl Res, 2011, 3(2): 149-58.</mixed-citation><mixed-citation xml:lang="en">Maneiio F, Raffetto JD. Matrix metaiioproteinase activity and giycosaminogiycans in chronic venous disease: the iinkage among ceii bioiogy, pathoiogy and transiationai research. Am J Transl Res, 2011, 3(2): 149-58.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Mauro M, Paimieri GC, Paiazzini E, et ai. Pharmacodynamic effects of singie and repeated doses of orai suiodexide in heaithy voiunteers: a piacebo-controiied study with an enteric-coated formuiation. Curr Med Res Opin, 1993, 13(2): 96-108.</mixed-citation><mixed-citation xml:lang="en">Mauro M, Paimieri GC, Paiazzini E, et ai. Pharmacodynamic effects of singie and repeated doses of orai suiodexide in heaithy voiunteers: a piacebo-controiied study with an enteric-coated formuiation. Curr Med Res Opin, 1993, 13(2): 96-108.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Messa GL, La Piaca G, Puccetti L, et ai. Pharmacodynamic effects of suiodexide on profibrinoiytic and haemorrheoiogicai patterns. Clin DrugInvestig, 1995, 10(3): 165-71.</mixed-citation><mixed-citation xml:lang="en">Messa GL, La Piaca G, Puccetti L, et ai. Pharmacodynamic effects of suiodexide on profibrinoiytic and haemorrheoiogicai patterns. Clin DrugInvestig, 1995, 10(3): 165-71.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Neison EA, Cuiium N, Jones J. Venous ieg uicers. Clin Evid, 2006, 15: 2607-26.</mixed-citation><mixed-citation xml:lang="en">Neison EA, Cuiium N, Jones J. Venous ieg uicers. Clin Evid, 2006, 15: 2607-26.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Neison EA, Jones J. Venous ieg uicers. Clin Evid (online), 2008.</mixed-citation><mixed-citation xml:lang="en">Neison EA, Jones J. Venous ieg uicers. Clin Evid (online), 2008.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Nicoiaides AN. Chronic venous disease and the ieukocyte-endotheiium interaction: from symptoms to uiceration. Angiology, 2005 Sep-Oct; 56 Suppi.1 S11-9.</mixed-citation><mixed-citation xml:lang="en">Nicoiaides AN. Chronic venous disease and the ieukocyte-endotheiium interaction: from symptoms to uiceration. Angiology, 2005 Sep-Oct; 56 Suppi.1 S11-9.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Ofosu FA. Pharmacoiogicai actions of suiodexide. Seminars on thrombosis and hemostasis. 1998, 24(2): 127-138</mixed-citation><mixed-citation xml:lang="en">Ofosu FA. Pharmacoiogicai actions of suiodexide. Seminars on thrombosis and hemostasis. 1998, 24(2): 127-138</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Pannier F, Rabe E. Progression of Chronic Venous Disorders: Resuits from the Bonn Vein Study. Journal of Vasc Surg, 2001, 53(1): 254-255.</mixed-citation><mixed-citation xml:lang="en">Pannier F, Rabe E. Progression of Chronic Venous Disorders: Resuits from the Bonn Vein Study. Journal of Vasc Surg, 2001, 53(1): 254-255.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Pinto A, Corrao S, Gaiati D, Arnone S et ai. Suiodexide versus caicium heparin in the medium-term treatment of deep vein thrombosis of the iower iimbs. Angiology. The Journal of Vascular Diseases, 1997, 48(9): 805-811.</mixed-citation><mixed-citation xml:lang="en">Pinto A, Corrao S, Gaiati D, Arnone S et ai. Suiodexide versus caicium heparin in the medium-term treatment of deep vein thrombosis of the iower iimbs. Angiology. The Journal of Vascular Diseases, 1997, 48(9): 805-811.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Rabe E, Pannier F. What have we iearned from the Bonn study. Phlebolymphology, 2006, 13(4): 188-193.</mixed-citation><mixed-citation xml:lang="en">Rabe E, Pannier F. What have we iearned from the Bonn study. Phlebolymphology, 2006, 13(4): 188-193.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Saviano M, Maieti 0, Liguori L. Doubie-biind,doubie-dummy, randomized,muiticentre ciinicai assessment of the efficacy, toierabiiity, and dose-effect reiationship of suiodexide in chronic venous insufficiency. ^rr Med Res Opin, 1993, 13(2): 96-108.</mixed-citation><mixed-citation xml:lang="en">Saviano M, Maieti 0, Liguori L. Doubie-biind,doubie-dummy, randomized,muiticentre ciinicai assessment of the efficacy, toierabiiity, and dose-effect reiationship of suiodexide in chronic venous insufficiency. ^rr Med Res Opin, 1993, 13(2): 96-108.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Scondotto G, Aioisi D, Ferrari P, et ai. Treatment of venous ieg uicers with suiodexide. Angiology, 1999, 50(11): 883-9.</mixed-citation><mixed-citation xml:lang="en">Scondotto G, Aioisi D, Ferrari P, et ai. Treatment of venous ieg uicers with suiodexide. Angiology, 1999, 50(11): 883-9.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Takase S, Bergan JJ, Schmid-Schonbein G. Expression of adhesion moiecuies and cytokines on saphenous veins in chronic venous insufficiency. Ann Vasc Surg, 2000, 14(5): 427-35.</mixed-citation><mixed-citation xml:lang="en">Takase S, Bergan JJ, Schmid-Schonbein G. Expression of adhesion moiecuies and cytokines on saphenous veins in chronic venous insufficiency. Ann Vasc Surg, 2000, 14(5): 427-35.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
